Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: ImmunoGen, Inc
Woman Max 99 years
ImmunoGen, Inc
Update Il y a 4 ans
A study to test mirvetuximab soravtansine (IMGN853) aganist doctor's choice of cancer medicines in adults with epithelial ovarian cancer, primary peritoneal cancer or primary fallopian tube cancer Un estudio para probar irvetuximab soravtansina (IMGN853) frente a los medicamentos que elija el médico en pacientes con cáncer epitelial de ovario, cáncer peritoneal primario o cáncer de las trompas de Falopio
Stage 1: -To determine the safety and anti-tumor activity of IMGN853 administered every 3 weeks and every 4 weeks -To select the schedule of IMGN853 to continue in Stage 2 Stage 2: -To compare the o...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
ImmunoGen, Inc
Update Il y a 4 ans
A clinical study to explore the efficacy and tolerability of IMGN529 taken together with Rituximab in patients with diffuse large B-cell lymphoma (DLBCL) or other forms of non-Hodgkin's lymphoma (NHL) who have stopped responding or have failed to respond to current cancer treatments
- Characterize the safety and tolerability of IMGN529 in combination with rituximab when administered IV every three weeks to adult patients with relapsed and/or refractory NHL - Determine the anti-t...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years and 85 years
ImmunoGen, Inc
Update Il y a 4 ans
Étude IMGN632 : étude de phase 1 randomisée évaluant la sécurité et l’efficacité de l’IMGN632 chez des patients ayant une leucémie aiguë myéloïde CD123-positive ou d’autres hémopathies malignes CD123-positives récidivantes ou réfractaires.
Les hémopathies malignes regroupent un ensemble de cancers des cellules sanguines et de leurs précurseurs. On retrouve les leucémies, les lymphomes, etc. Les cellules souches hématopoïétiques sont fab...
Country
France
organs
Leucémies aiguës
,
Syndromes myélodysplasiques (SMD)
,
Sang Hématologie - Autres
Specialty
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information